Business Wire

CA-JUNIPER-NETWORKS

11.3.2024 20:26:32 CET | Business Wire | Press release

Share
Gartner® Names Juniper Networks a Leader in 2024 Magic Quadrant™ for Enterprise Wired and Wireless LAN Infrastructure for Fourth Time in a Row

Juniper Networks (NYSE: JNPR), a leader in secure AI-Native Networking, today announced that Gartner, Inc. has named it a Leader in the 2024 Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure for the fourth time in a row. In the latest iteration of this Magic Quadrant, for the third time straight, Juniper is also positioned furthest in “Completeness of Vision,” a Gartner rating criterion that reflects innovation, and evaluates vendors on their ability to communicate that they understand client business issues in their target markets and have the products, services, vision and strategies to address these issues. In addition, Juniper was once again positioned highest for “Ability to Execute,” a Gartner rating criterion that evaluates vendors on their product/service, market responsiveness and customer experience.

As Gartner explains, “Magic Quadrants offer visual snapshots, in-depth analyses and actionable advice that provide insight into a market’s direction, maturity and participants. Assessing the market and its technology and service providers is a business-critical task. Vendor differentiation based on variations in operations, customer satisfaction, level of complexity and strategy can make comparisons of vendor offerings challenging. In addition, the market’s overall direction is often evolving. Gartner’s Magic Quadrants solve these problems by offering snapshots of markets and their participants, and help you map vendor strengths and cautions against your current and future needs.”

“We believe this latest recognition as a Leader by Gartner reinforces the value our products deliver for our customers,” said Sudheer Matta, Group Vice President, Products for the AI-Native Enterprise, Juniper Networks. “By delivering full-stack automation, insight and self-driving actions, Mist AI continues to stand out from the rest of the industry for fast deployments, the fewest tickets and quickest problem resolution. The momentum we are seeing is a true testament to our vision to design the industry’s first AI-Native Networking Platform from the ground up to provide reliable and consistent Wi-Fi experiences. By using automation to reduce or eliminate time-consuming manual tasks, and implementing automated workflows to proactively fix issues before they impact users, we consistently deliver proven value, saving substantial time and money for our customers and partners worldwide.”

In addition, Juniper recently announced record 2023 revenue results, marking the third consecutive year of business growth on a year-over-year basis. Juniper’s AI-Native enterprise solutions significantly outpaced the market, with revenue from wired and wireless access products attached to the Mist cloud growing nearly 70% on a full-year basis.

And as reported by the 650 Group Wireless LAN Infrastructure Quarterly Market & Long-Term Forecast Report 4Q23, published on March 1, 2024, while most of the industry contracted in Q4, Juniper continued its strong growth both Q/Q and Y/Y. In addition, Juniper was the fastest growing vendor on a full calendar year basis from 2022 to 2023.

Juniper solutions are deployed and helping drive better connections in 4 of the Fortune 10, 3 of the top-3 retailers, 2 of the top-5 Fintech companies, top Global universities, and the #1 healthcare provider in the United States. And Juniper’s public customer wins continue to expand across all verticals, with a host of new public success stories, including:

James Cook University Singapore

Seacoast Bank

City of Parkland Florida

ServiceNow

Juniper’s recognition in the Magic Quadrant for latest Enterprise Wired and Wireless LAN Infrastructure report is in addition to Gartner also recently naming Juniper Networks a Leader in the 2024 Gartner Magic Quadrant for Indoor Location Services for the third year in a row.

As the only vendor named a Leader in both the Wired and Wireless LAN Infrastructure and Indoor Location Services Magic Quadrant reports, Juniper believes its solutions are uniquely positioned to deliver exceptional experiences for both operators and end users. Automation in Juniper’s wired and wireless solutions not only helps accelerate deployments and eliminate up to 90% of networking-related trouble tickets, but our indoor location services offer customers and partners a scalable and cost-effective way to personalize wireless experiences with value-added features like wayfinding, asset location, and contextual notifications.

Additional Resources

Gartner Disclaimer

Gartner, Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure, Tim Zimmerman, Christian Canales, Nauman Raja, Mike Leibovitz 6 March 2024.

Gartner Magic Quadrant for Indoor Location Services, Global, Tim Zimmerman, Annette Zimmermann, et al., 28 February 2024.

Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved. Juniper Networks is recognized as Juniper in the 2024, 2022, and 2021 Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure reports.

About Juniper Networks

Juniper Networks believes that connectivity is not the same as experiencing a great connection. Juniper's AI-Native Networking Platform is built from the ground up to leverage AI to deliver the best and most secure user experiences from the edge to the data center and cloud. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on X (Twitter) LinkedIn and Facebook.

Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240311703596/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye